Stocks · Korea
002720
KOSPI
Kukje Pharma
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER15.82x
PBR0.96x
EPS280 KRW
BPS4,617 KRW
ROE6.08%
Dividend yield0.68%
DPS30 KRW
Payout ratio10.71%
Returns and 52-week range
1W+36.94%
1M+30.87%
3M+31.07%
6M-9.03%
1Y-3.90%
YTD+1.96%
52W high5,470원
52W low2,810원
From 52W high-19.01%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 1,266억 | 53억 | 35억 | 4.2% |
| 2023 | 1,354억 | -20억 | -84억 | -1.5% |
| 2024 | 1,565억 | 67억 | 52억 | 4.3% |
| 2025 | 1,755억 | 62억 | 57억 | 3.5% |
| Quarterly | ||||
| 2024 4Q | 416억 | 9억 | 7억 | 2.3% |
| 2025 1Q | 415억 | 23억 | 19억 | 5.5% |
| 2025 2Q | 450억 | 35억 | 27억 | 7.8% |
| 2025 3Q | 456억 | 19억 | 19억 | 4.2% |
| 2025 4Q | 433억 | -15억 | -7억 | -3.6% |
| 2026 1Q | 440억 | 20억 | 21억 | 4.5% |
Company
Address: 경기도 성남시 분당구 야탑로 96-8
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
- 2026-03-18사업보고서 (2025.12)
- 2025-12-19주요사항보고서(자기주식처분결정) Major
- 2025-11-14분기보고서 (2025.09)
- 2025-08-14반기보고서 (2025.06)
- 2025-05-15분기보고서 (2025.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.